We're absolutely delighted to share this exciting news from the @uniQure_NV AMT-130 trial ucl.ac.uk/news/2025/sep/gene…

We’re recruiting a Senior Research Technician to work on Huntington’s disease and DNA repair modifier biology. A fantastic opportunity to be part of Prof Sarah Tabrizi’s collaborative lab team at @UCLIoN @UKDRI. Apply here by 26 May👇 ucl.ac.uk/work-at-ucl/search…

The UCL HD Centre is recruiting: Executive Assistant to Professor Sarah Tabrizi (maternity cover). Deadline for applications is 6 May. Apply here: ucl.ac.uk/work-at-ucl/search…

This week, a team shows that lowering the highly toxic Htt1a transcript with siRNA delays #Huntingtin aggregation and corrects transcriptional dysregulation more effectively than targeting full-length, mutant HTT. @UCLHD #HuntingtonsDisease scim.ag/4uZoOer

Still feels surreal to say that I successfully defended my PhD viva with no corrections. Huge thanks to my examiners (Prof Rosser and Prof Rohrer) and to my incredible supervisors (Prof Tabrizi, Prof Scahill and Prof Wild) for their guidance and support throughout this journey. I’m also forever grateful to everyone @UCLHD @UCLIoN who supported me along the way. As written in my thesis dedication: for the #HD community. #PhDone 🥳

This #IWD2026 we spotlight Prof Sarah Tabrizi - leader in #Huntingtonsdisease research and long-standing BNA member. Sarah reflects on: • Resilience in long-term research • Her connection with patients • Advice for ECRs @UCLIoN @ucl @UCLHD piped.video/SPQ5a4Qn7CM

The current HD-ISS doesn't incorporate wet biomarkers. Dr. Mena Farag discusses the promising results of proenkephalin and other biomarkers to help monitor the earliest stages of HD before the onset of motor symptoms. @MDJ_Journal movementdisorders.org/Podcas…

So much @UCLHD love at my leaving do! Thank you to everyone who made the last three years of my PhD journey such a joy. @UCLBrainScience @UCLIoN

Signing off from the @LWENCCRF with this wonderful team. 3 years of teamwork, learning and shared commitment to our #HD clinical trials @UCLHD @UCLIoN - thank you all for making it so special.

Our featured article for January is a Review on somatic CAG expansions and the potential for therapeutic interventions, from Sarah Tabrizi and colleagues. Free to read here: rdcu.be/eXFmV

Discovery of disrupted sustained attention and altered functional connectivity in far‐from‐onset Huntington's disease gene‐expanded young adults alz-journals.onlinelibrary.w…

Discovery of disrupted sustained attention and altered functional connectivity in far‐from‐onset Huntington's disease gene‐expanded young adults - Langley - 2026 - Alzheimer's & Dementia - Wiley Online Library alz-journals.onlinelibrary.w…

Titans of Science returns with Edward Wild and Sarah Tabrizi (@ucl, @UCLHD and @UCLIoN), who recently announced that Huntington's disease had been successfully treated for the first time. #Huntingtons #TitansOfScience #BrainHealth #Genetics thenakedscientists.com/podca…

Congratulations @DrMFarag from @UCLHD! 👏 @UKDRI @UCLIoN @UCLBrainScience @ucl ucl.ac.uk/brain-sciences/new…

1/5 Sarah Tabrizi (@UCLHD)🇬🇧 Focus: Neurodegenerative Disease Nature calls her a "Hero." Our map shows why: She sits at the perfect intersection of basic neurology and clinical application. Look at the density of her clinical trial connections compared to pure lab research. 🔗 bohrium.com/scholar/4236B15O… #Huntingtons #Neurology #ClinicalResearch

We're delighted that Professor Sarah Tabrizi (@UCLIoN) is part of Nature’s 10, a list of people who shaped science in 2025. Her team's global trial at @UCLHD showed a new Huntington’s treatment could slow progression by 75%. nature.com/articles/d41586-0…

I am incredibly honoured to share that I have been awarded the @UKDRI PhD Prize at #Connectome 2025! My heartfelt thanks go to my superb PhD supervisors (Professors Sarah Tabrizi, Rachael Scahill and Ed Wild) and to my thesis committee (Professors Geraint Rees and Henrik Zetterberg). I’m also very grateful to all our collaborators, and to my supportive colleagues and friends @UCLHD @UCLIoN. Above all, I want to thank the incredible #HD-YAS participants, whose commitment, generosity and time have made this work possible. As my PhD journey comes to an end, it has been a privilege to contribute to research that brings us closer to preventive therapies for Huntington’s disease, and I’m truly humbled to receive this recognition.

The 2025 BNA prize-giving ceremony will be held at the Festive Symposium. Sarah Tabrizi @ucl will receive her Outstanding Contribution to Neuroscience Award, and we’ll reveal winners for #Undergraduate, #Postgraduate & #PublicEngagement prizes. bna.org.uk/events/festive-sy…

The BNA is thrilled to announce that Professor Sarah Tabrizi has won the 2025 Outstanding Contribution to #Neuroscience Award. Her ground-breaking work is transforming hope and treatment prospects for people with #Huntingtonsdisease. bna.org.uk/resource/professo… #ResearchImpact

🏆 1/ Professor Sarah Tabrizi, Director of the UCL Huntington’s Disease Centre (@UCLHD), was awarded the @BritishNeuro Outstanding Contribution to Neuroscience Award for 2025, the association’s top annual prize. ucl.ac.uk/news/2025/nov/pion…